Securities code: 300436 securities abbreviation: Fujian Cosunter Pharmaceutical Co.Ltd(300436) Announcement No.: 2022012 Fujian Cosunter Pharmaceutical Co.Ltd(300436)
Announcement on the completion of cancellation of some stock options
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Fujian Cosunter Pharmaceutical Co.Ltd(300436) (hereinafter referred to as “the company”) held the 10th meeting of the 4th board of directors and the 9th meeting of the 4th board of supervisors on January 14, 2022, deliberated and adopted the proposal on canceling some stock options in the 2020 stock option incentive plan: according to the relevant provisions of the company’s 2020 stock option incentive plan, A total of 1204000 stock options that cannot be exercised due to the resignation of 13 original incentive objects of the company due to personal reasons and non-compliance with incentive conditions will be cancelled. After this cancellation, the company’s 2020 stock option incentive plan has been granted with the remaining 1.596 million stock options. For details, please refer to the company’s website (www.cn. Info. Com. CN.) on January 17, 2022 Announcement on cancellation of some stock options of 2020 stock option incentive plan (Announcement No.: 2022006).
After examination and confirmation by Shenzhen Branch of China Securities Depository and Clearing Co., Ltd., the cancellation of the above stock options has been completed recently.
It is hereby announced!
Fujian Cosunter Pharmaceutical Co.Ltd(300436) board of directors February 7, 2022
